| Emmaus Life Sciences is a predictive analytics company. Co. employs a platform to support personalized care for mental health patients. Co. utilizes its machine learning, artificial intelligence, data analytics platform for the delivery of telebehavioral health services and its Psychiatric Electroencephalograms (EEGs) Evaluation Registry (PEER) predictive analytics product offering. Co.'s platform (PEER Online) utilizes algorithms to analyze EEGs to generate PEER Reports to predict individual responses to a range of medications prescribed for the treatment of behavioral disorders including depression, anxiety, bipolar disorder, post-traumatic stress disorder and other non-psychotic disorders. We show 12 historical shares outstanding datapoints in our coverage of MYND's shares outstanding history.|
Understanding the changing numbers of MYND shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like MYND versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching MYND by allowing them to research MYND shares outstanding history
as well as any other stock in our coverage universe.